NCT03682978View on ClinicalTrials.gov

Arbaclofen in Children and Adolescents With ASD

PHASE2CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

September 19, 2019

Primary Completion Date

January 27, 2023

Study Completion Date

January 27, 2023

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Arbaclofen

Arbaclofen tablet.

DRUG

Placebo

Placebo tablet.

Trial Locations (7)

28009

Servicio de Psiquiatría del Niño y del Adolescente, Hospital General Universitario Gregorio Marañón, SERMAS, Madrid

75019

Robert Debré Hospital, Paris

08036

Hospital Clínic de Barcelona, Barcelona

Unknown

University of Salamanca & Complejo asistencial de Zamora, Salamanca

G78 1SL

University of Glasgow, Glasgow

SE5 8AF

King's College London, London

NE1 7RU

University of Newcastle upon Tyne, Newcastle

All Listed Sponsors
collaborator

UMC Utrecht

OTHER

lead

Celso Arango, MD, PhD

OTHER

NCT03682978 - Arbaclofen in Children and Adolescents With ASD | Biotech Hunter | Biotech Hunter